Vidhi Shanghvi, along with her brother Aalok Shanghvi, is set to inherit the ₹4.35 lakh crore healthcare empire built by their father, Dilip Shanghvi, founder of Sun Pharmaceutical Industries. The company, one of the largest in the global pharmaceutical industry, has made a significant mark worldwide.
Education and Career Path
Vidhi is an Economics graduate from the prestigious Wharton School at the University of Pennsylvania, equipping her with the skills to understand the complexities of the healthcare sector. She currently serves as Vice President at Sun Pharmaceutical Industries, where she began her career in the marketing department of the India Business division. Her strategic insights and hands-on approach have played a key role in the company’s growth.
Passion for Mental Health
Apart from her professional work, Vidhi is passionate about mental health advocacy. She founded Mann Talks, a non-profit initiative providing free and holistic mental health solutions. Through this, she aims to encourage people to focus on their well-being and lead healthier lives.
Sun Pharmaceutical’s Global Reach
Under Dilip Shanghvi’s leadership, Sun Pharma has grown to be the fourth-largest specialty generic pharmaceutical company globally. With global revenues of $5.4 billion (₹44,820 crore), the company operates 43 manufacturing facilities, delivering quality medicines to over 100 countries.
Dilip Shanghvi’s Success and Legacy
As of December 2024, Forbes lists Dilip Shanghvi as India’s richest healthcare billionaire, with a net worth of $29.2 billion (₹2,42,360 crore). His vision has firmly established Sun Pharma as a leader in the pharmaceutical industry, and Vidhi Shanghvi is well-positioned to continue his legacy.
